文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症危重患者的临床亚型:验证与简约分类模型开发

Clinical subtypes in critically ill patients with sepsis: validation and parsimonious classifier model development.
PubMed 文献 · Crit Care · 2025-02-04
一句话结论在多个ICU队列中,三变量(天冬氨酸氨基转移酶、血清乳酸、碳酸氢盐)模型能较准确识别δ型脓毒症患者。

研究使用2008至2023年间四个队列(MARS、MARS2、NICE、MIMIC-IV)的52,226例脓毒症患者,验证既往SENECA临床亚型(α、β、γ、δ型)并开发简约分类模型。亚型分布在美国与欧洲队列间差异明显,MARS、MARS2和NICE中γ型占49-65%、δ型占26-48%,而MIMIC-IV中四种亚型分布较均匀(25%、24%、27%、25%)。α、γ、δ型的院内死亡率在四个队列间有显著差异(p < 0.001)。基于三个变量(天冬氨酸氨基转移酶、血清乳酸、碳酸氢盐)的简约模型在推导队列中识别δ型患者的AUC为0.93(95% CI 0.92-0.94),在MARS验证队列中AUC 0.93(95% CI 0.92-0.94)、准确率85.5%(84.0-86.8%),在MIMIC-IV中AUC 0.86(95% CI 0.85-0.87)、准确率82.9%(82.4-83.4%)。

要点

  • 在52,226例脓毒症患者中,MARS、MARS2和NICE队列的γ型占49-65%、δ型占26-48%,α型占2-6%、β型占1-5%。
  • MIMIC-IV队列亚型分布更接近原始SENECA推导队列:α型25%、β型24%、γ型27%、δ型25%(原始为33%、27%、27%、13%)。
  • α、γ、δ型的院内死亡率在四个队列间差异显著(p < 0.001)。
  • 三变量(天冬氨酸氨基转移酶、血清乳酸、碳酸氢盐)模型在推导队列识别δ型的AUC为0.93(95% CI 0.92-0.94),在MARS验证队列准确率85.5%(84.0-86.8%),在MIMIC-IV准确率82.9%(82.4-83.4%)。
  • 预测全部四种亚型的简约模型准确率中等至偏低(准确率62.2%)。

适用人群与场景

  • 符合Sepsis-3标准的ICU脓毒症患者,数据来自MARS(n=2449)、MARS2(n=2445)、NICE(n=28,621)和MIMIC-IV(n=18,661)四个队列,时间跨度为2008至2023年。

诊断标准与关键阈值

  • 使用临床变量通过K-means聚类评估最佳类别数,并与SENECA亚型比较;亚型判定基于临床变量分为α、β、γ、δ四型。
  • δ型简约分类模型使用三个变量:天冬氨酸氨基转移酶、血清乳酸、碳酸氢盐,通过逻辑回归建模。

研究设计与关键结果

  • 研究类型为多队列验证与模型开发研究,共纳入52,226例脓毒症患者,来自四个队列(MARS、MARS2、NICE、MIMIC-IV)。
  • 亚型分布:MARS、MARS2和NICE中α型2-6%、β型1-5%、γ型49-65%、δ型26-48%;MIMIC-IV中α型25%、β型24%、γ型27%、δ型25%;原始SENECA推导队列为α型33%、β型27%、γ型27%、δ型13%。
  • α、γ、δ型的院内死亡率在四个队列间差异显著(p < 0.001)。
  • 基于方法的验证显示,在MARS和MIMIC-IV中与原始亚型有中等程度重叠。
  • 预测全部四种亚型的简约模型准确率中等至偏低(准确率62.2%)。
  • 三变量(天冬氨酸氨基转移酶、血清乳酸、碳酸氢盐)简约分类模型识别δ型与其他类型的效能:推导队列AUC 0.93(95% CI 0.92-0.94),准确率85.5%(84.0-86.8%);MARS验证队列AUC 0.93(95% CI 0.92-0.94),准确率85.5%(84.0-86.8%);MIMIC-IV验证队列AUC 0.86(95% CI 0.85-0.87),准确率82.9%(82.4-83.4%)。

证据类型、等级与局限

  • 证据类型:多队列验证与模型开发研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,三变量模型能准确识别δ型脓毒症患者,但亚型分布和死亡率在美国与欧洲队列间存在差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The application of sepsis subtypes to enhance personalized medicine in critically ill patients is hindered by the lack of validation across diverse cohorts and the absence of a simple classification model. We aimed to validate the previously identified SENECA clinical sepsis subtypes in multiple large ICU cohorts, and to develop parsimonious classifier models for δ-type adjudication in clinical practice.

METHODS: Data from four cohorts between 2008 and 2023 were used to assign α, β, γ and δ-type in patients fulfilling the Sepsis-3 criteria using clinical variables: (I) The Molecular diAgnosis and Risk stratification of Sepsis (MARS, n = 2449), (II) a contemporary continuation of the MARS study (MARS2, n = 2445) (III) the Dutch National Intensive Care Evaluation registry (NICE, n = 28,621) and (IV) the Medical Information Mart for Intensive Care including (MIMIC-IV, n = 18,661). K-means clustering using clinical variables was conducted to assess the optimal number of classes and compared to the SENECA subtypes. Parsimonious models were built in the SENECA derivation cohort to predict subtype membership using logistic regression, and validated in MARS and MIMIC-IV.

RESULTS: Among 52.226 patients with sepsis, the subtype distribution in MARS, MARS2 and NICE was 2-6% for the α-type, 1-5% for the β-type, 49-65% for the γ-type and 26-48% for the δ-type compared to 33%, 27%, 27% and 13% in the original SENECA derivation cohort, whereas subtype distribution in MIMIC-IV was more similar at 25%, 24%, 27% and 25%, respectively. In-hospital mortality rates were significantly different between the four cohorts for α, γ and δ-type (p < 0.001). Method-based validation showed moderate overlap with the original subtypes in both MARS and MIMIC-IV. A parsimonious model for all four subtypes had moderate to low accuracy (accuracy 62.2%), while a parsimonious classifier model with 3 variables (aspartate aminotransferase, serum lactate, and bicarbonate) had excellent accuracy in predicting the δ-type patients from all other types in the derivation cohort and moderate accuracy in the validation cohorts (MARS: area under the receiver operator characteristic curve (AUC) 0.93, 95% CI [0.92-0.94], accuracy 85.5% [84.0-86.8%]; MIMIC-IV: AUC 0.86 [0.85-0.87], accuracy 82.9% [82.4-83.4%]).

CONCLUSIONS: The distribution and mortality rates of clinical sepsis subtypes varied between US and European cohorts. A three-variable model could accurately identify the δ-type sepsis patients.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. van Amstel RBE, Rademaker E, Kennedy JN, et al. Clinical subtypes in critically ill patients with sepsis: validation and parsimonious classifier model development. Crit Care. 2025. PMID: 39905513. doi:10.1186/s13054-025-05256-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。